Skip to content
Anupam Rasayan logo

Anupam Rasayan India

ANURAS NSE
₹1,145.40 +5.80 (+0.51%)
P/E
74.62
View as Markdown
MCP
Close 4 Nov 2026 ₹1,145.40 +76.90 +7.20% 1Y
Start ₹1,068.50

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
7.38%
Debt to Equity
0.57
EPS (TTM)
₹15.35
Book Value
₹290.02
Market Cap
—
P/E (TTM)
74.62
P/B
3.95
ROE
5.55%
Dividend Yield
0.13%
EBITDA
₹543 Cr
52W High
₹1,415.00
52W Low
₹1,053.60
Day Range
₹1,137.00 – ₹1,152.50
Volume
2,18,508

Peer Comparison

Commodities › Chemicals › Specialty Chemicals

Anupam Rasayan peer comparison
₹1,510.2058.04₹1,54,107 Cr13.721.42%23.90%31.00%₹15,399 Cr₹2,677 Cr
₹4,613.3083.76₹49,073 Cr6.040.07%7.82%9.64%₹5,303 Cr₹600 Cr
₹8,785.0057.03₹44,060 Cr10.100.09%19.60%21.00%₹3,634 Cr₹789 Cr
₹1,578.4027.48₹20,919 Cr3.320.49%9.82%11.40%₹8,575 Cr₹784 Cr
₹1,540.7086.90₹20,030 Cr7.880.00%9.66%11.90%₹1,231 Cr₹235 Cr
₹447.5530.57₹15,838 Cr2.590.23%7.13%6.86%₹9,010 Cr₹531 Cr
₹5,156.5019.67₹14,827 Cr2.310.59%11.50%14.90%₹6,969 Cr₹788 Cr
Anupam Rasayan (this company)
₹1,145.4074.62₹12,985 Cr3.950.13%5.55%7.38%₹2,535 Cr₹225 Cr
Median 8 companies₹1,559.5557.54₹20,474 Cr5.000.18%9.74%11.65%₹6,136 Cr₹692 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

44 Weak

Data confidence 100/100

pledge:33%

Category scores

Quality
41
Weak
Returns, margins, earnings quality 22% weight
Valuation
21
Poor
Cheap vs sector & own history 24% weight
Growth
99
Strong
Sales & profit trajectory 9% weight
Financial Health
29
Poor
Solvency, leverage, coverage 9% weight
Momentum
26
Poor
Trend strength, vol-adjusted 12% weight
Ownership
83
Strong
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is expected to give good quarter

Weaknesses

4
  • Stock is trading at 4.05 times its book value
  • Tax rate seems low
  • Company has a low return on equity of 4.61% over last 3 years.
  • Dividend payout has been low at 9.85% of profits over last 3 years

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish865
OscillatorsBullish162
Moving AveragesStrong Bearish703

Key readings

RSI (14)
48.10
Neutral
MACD (12,26,9)
−9.94
Bullish
SMA (50)
1,184.28
Bearish
SMA (200)
1,255.19
Bearish

As of

Analyst Rating

Based on 4 analysts
BUY75%

3 of 4 analysts rate Buy, 0 Hold, 1 Sell.

As of

BUY
3
75%
HOLD
0
0%
SELL
1
25%

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
5Y+23.87%
3Y+13.86%
1Y+64.58%
TTM+51.74%

Net profit

Net profit growth by window
5Y+25.97%
3Y+0.76%
1Y+38.75%
TTM+14.80%

Operating cash flow

Operating cash flow growth by window
5Y+219.70%
3Y+4.58%
1YTurned positive
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
5Y−1.68 pp
3Y−4.66 pp
1Y−5.67 pp
TTM−6.08 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2019₹502 Cr
Mar 2020₹529 Cr
Mar 2021₹811 Cr
Mar 2022₹1,074 Cr
Mar 2023₹1,602 Cr
Mar 2024₹1,475 Cr
Mar 2025₹1,437 Cr
Mar 2026₹2,365 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2019₹49.00 Cr
Mar 2020₹53.00 Cr
Mar 2021₹70.00 Cr
Mar 2022₹152 Cr
Mar 2023₹217 Cr
Mar 2024₹167 Cr
Mar 2025₹160 Cr
Mar 2026₹222 Cr

Analyst Forecasts

Forecast For
FY27 consensus · EBITDA
₹807 Cr +48.6% vs FY26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 28 Oct 2026
AI opinion · based on fundamentals
Risk high

Anupam Rasayan India Ltd trades at ₹1,151.4 as of 2026-10-28 with a market cap of ₹13,108.67 Cr. The company has delivered strong TTM sales growth of 52% and TTM profit growth of 42%, but carries a rich PE of 75.01x and a modest ROE of 4.8%, presenting a mixed picture of high growth against stretched valuations and subdued return ratios.

Bull Case 8
  • TTM revenue growth of 52% is exceptionally strong, indicating a sharp acceleration in top-line momentum compared to the 3-year sales CAGR of 14%
  • TTM profit growth of 42% shows significant earnings recovery and operating leverage after a 3-year compounded profit CAGR of -2%
  • 5-year compounded sales CAGR of 24% demonstrates a sustained long-term growth trajectory in the specialty chemicals space
  • 5-year compounded profit CAGR of 19% reflects the company's ability to scale profitably over a longer horizon despite near-term earnings volatility
  • Debt-to-equity ratio of 0.57 is manageable and suggests the balance sheet is not over-leveraged, providing room for future capex funding
  • The stock is trading at ₹1,151.4, which is 18.6% below its 52-week high of ₹1,415, suggesting it has corrected from peak levels
  • The company is expected to deliver a good upcoming quarter, which could act as a near-term positive catalyst for earnings sentiment
  • Stock price CAGR of 11% over 3 years shows the market has rewarded the company's growth story with steady capital appreciation
Bear Case 7
  • ROE of 4.8% is low, and the 3-year average ROE of roughly 5% indicates the company is generating poor returns on shareholders' equity
  • ROCE of 7.47% is modest, suggesting the company's deployed capital is not generating strong economic returns relative to its cost of capital
  • Price-to-book ratio of 3.97x (approximately 4.05x book value) is elevated for a company delivering sub-5% ROE, signaling a valuation-return mismatch
  • Dividend yield of just 0.13% and a payout ratio of only 9.85% of profits over the last 3 years offer negligible income to shareholders
  • 3-year compounded profit CAGR of -2% shows that until the recent TTM surge, earnings had been stagnant or declining
  • Tax rate appears low, which if normalized upward could compress net margins and reduce the EPS base supporting the current valuation
  • The stock is only 9.3% above its 52-week low of ₹1,053.6, indicating it has been under sustained selling pressure over recent months

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

3d ago

TL;DR: Anupam Rasayan promoters released pledges on over 1.16 crore shares across Oct 5-6, signalling improving promoter-level financial health. While the trend is clearly positive, encumbered shares still account for roughly 15% of share capital. No operational or sector-specific headwinds emerged this week. Continued pledge reduction would further strengthen investor confidence.

Positives 1
  • Promoter pledge steadily reducing Oct 5

    Rehash Industrial released a pledge on 50 lakh shares after repaying a Tata Capital loan, followed by Catalyst Trusteeship releasing 66.05 lakh shares on Oct 6. Combined 1.16 crore shares unlocked in two days.

Neutral 1
  • Encumbered shares still at 14.9% Oct 6

    After the two pledge releases, remaining encumbered promoter shares stand at 1,69,66,785 representing 14.90% of total share capital — still a meaningful level to monitor.

Quarterly Results

₹ Cr
ANURAS quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
386
392
296
401
254
294
390
500
486
731
512
636
655
Expenses
285
285
216
308
201
214
266
356
362
596
385
498
493
Operating Profit
101
107
79
93
53
80
124
144
124
136
127
137
162
OPM %
26%
27%
27%
23%
21%
27%
32%
29%
26%
19%
25%
22%
25%
Other Income
12
3
2
12
6
2
−4
6
5
8
2
3
13
Interest
18
20
25
26
22
27
32
31
36
36
35
42
49
Depreciation
19
20
20
21
21
22
29
31
31
32
34
43
56
PBT
77
71
36
58
16
34
59
88
63
76
60
56
70
Tax %
32%
31%
28%
30%
25%
10%
9%
29%
23%
24%
−1%
0%
27%
Net Profit
52
49
26
40
12
31
54
63
48
57
61
56
51
EPS (₹)
3.59
3.78
1.68
2.82
0.36
1.52
2.56
4.05
3.1
3.9
4.31
3.75
3.39

Profit & Loss

₹ Cr
ANURAS profit and loss, annual, ₹ crore
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
502
529
811
1,074
1,602
1,475
1,437
2,365
2,535
Expenses
408
394
617
769
1,171
1,094
1,036
1,840
1,972
Operating Profit
93
135
194
305
431
381
401
526
563
OPM %
19%
25%
24%
28%
27%
26%
28%
22%
22%
Other Income
19
11
26
8
10
30
11
18.17
26
Interest
24
45
69
31
63
89
112
149
162
Depreciation
23
29
52
60
71
80
102
140
165
PBT
66
72
100
222
308
242
198
254
261
Tax %
24%
26%
30%
31%
30%
31%
19%
13%
—
Net Profit
49
53
70
152
217
167
160
222
225
EPS (₹)
9.85
10.64
7.04
15.18
16.83
11.71
8.49
14.94
15.35
Div. Payout %
0%
0%
7%
7%
15%
11%
9%
10%
—

Balance Sheet

₹ Cr
ANURAS balance sheet, annual, ₹ crore
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
50
50
100
100
107
110
110
114
Reserves
432
515
1,473
1,627
2,265
2,651
2,740
3,188
Borrowings
694
847
423
836
822
1,069
1,373
1,867
Other Liabilities
146
252
301
327
584
772
1,045
2,843
Total Liabilities
1,323
1,664
2,298
2,891
3,778
4,602
5,269
8,013
Fixed Assets
681
977
1,115
1,202
1,417
1,501
2,185
3,713
CWIP
191
101
43
44
120
609
216
114
Investments
0
0
0
149
67
67
9
19
Other Assets
451
586
1,140
1,496
2,173
2,424
2,860
4,167
Total Assets
1,323
1,664
2,298
2,891
3,778
4,602
5,269
8,013

Cash Flow

₹ Cr
ANURAS cash flow, annual, ₹ crore
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
39
95
1
−171
292
59
−30
334
Investing
−250
−178
−193
−412
−523
−392
−330
−820
Financing
206
102
416
384
371
395
223
621
Net Cash Flow
−6
19
224
−199
140
62
−137
135
Free Cash Flow
−209
−85
−144
−318
232
−644
−440
−220
CFO/EBITDA
55
77
10
−44
84
28
3
72

Ratios

ANURAS financial ratios, annual
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
88
89
92
95
95
143
186
148
Inventory Days
277
515
530
852
483
627
876
490
Days Payable
105
226
215
225
167
247
348
261
Cash Conversion Cycle
260
379
408
722
410
524
715
377
Working Capital Days
56
21
168
218
153
138
160
108
ROCE %
—
9%
10%
11%
13%
9%
7%
7%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Anupam Rasayan insights

67 extracted metrics across FY14–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 59.07%
  • Public 20.68%
  • Others 9.33%
  • FIIs 8.66%
  • DIIs 2.27%

32.85% of promoter holding pledged as of Sep 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Anupam Rasayan India

What does Anupam Rasayan India Ltd do?
Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries.
Where is Anupam Rasayan India Ltd (ANURAS) listed?
Anupam Rasayan India Ltd trades as ANURAS on the NSE and under code 543275 on the BSE.
Which sector does Anupam Rasayan India Ltd belong to?
Anupam Rasayan India Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the PE ratio of Anupam Rasayan India Ltd?
Anupam Rasayan India Ltd trades at a PE ratio of 74.62 as of 4 Nov 2026, on earnings per share of ₹15.35, against a book value of ₹290.02 per share.
What is the 52-week high and low of Anupam Rasayan India Ltd?
Over the last 52 weeks Anupam Rasayan India Ltd has traded between ₹1,053.6 and ₹1,415 as of 4 Nov 2026.
Does Anupam Rasayan India Ltd pay dividends?
Anupam Rasayan India Ltd has a dividend yield of 0.13%.
What is the Return on Equity (ROE) of Anupam Rasayan India Ltd?
Anupam Rasayan India Ltd reported a return on equity of 5.55%. Its debt-to-equity ratio is 0.57.

Company Information

Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries.

CEO Mr. Gopal Puranmal Agrawal
Employees 2,606
Listed 24 Mar 2021
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ANURAS.md for Anupam Rasayan India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More